14.3 Generalized Anxiety Disorder GAD Trials in Adults (Including Geriatric Patients) The efficacy of CYMBALTA in the treatment of generalized anxiety disorder (GAD) was established in 1 fixed-dose randomized, double-blind, placebo-controlled trial and 2 flexible-dose randomized, double-blind, placebo-controlled trials in adult outpatients between 18 and 83 years of age meeting the DSM-IV criteria for GAD (Studies GAD-1, GAD-2, and GAD-3, respectively)
BPC 157: Uses, Dosages, Benefits and Side Effects Dec 162024 Uses of BPC 157 Body Protection Compound 157 (BPC 157) is a peptide consisting of 15 amino acids
This means that it mimics the action of BDNF by binding to the same receptor in the brain as natural BDNF
Int J Vitam Nutr Res 74, 269278 (2004)
Yes, you can switch between injection and oral forms based on your preference and lifestyle